Metraipolis › archive › dc_33cb57f508a9

Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a… — Europe PMC PMID:41675439

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41675439
DOI
10.1016/j.lanepe.2026.101597
License (as archived)
solo-consultazione
Archived
2026-11-06T03:43:43.396Z
SHA-256 of the archived text
55eb4f5b8a17a04bbdb97d7f8f095114f9f04c018d63294798bb9a04da6aea93
Stable URL of this page
https://metraipolis.com/documento/dc_33cb57f508a9

How to cite

Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a… — Europe PMC PMID:41675439 — Europe PMC (en), https://europepmc.org/article/MED/41675439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_33cb57f508a9 (Metraipolis archive dc_33cb57f508a9, sha256 55eb4f5b8a17a04bbdb97d7f8f095114f9f04c018d63294798bb9a04da6aea93)
BibTeX
@misc{dc33cb57f508a9,
  title = {Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a… — Europe PMC PMID:41675439},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41675439},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_33cb57f508a9; sha256 55eb4f5b8a17a04bbdb97d7f8f095114f9f04c018d63294798bb9a04da6aea93},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41675439. Agents can read the archived copy with the MCP tool read_document.